RZLT
RZLT
NASDAQ · Biotechnology

Rezolute Inc

$3.18
+0.49 (+18.22%)
As of Mar 25, 10:06 PM ET ·
Analyst Consensus
Buy
16
Analysts
High
Coverage
Buy 11 69%
Hold 5 31%
Sell 0 0%
Price Target
Analyst Price Target +445.6% upside
Low Target $11.58
Average Target $17.35
High Target $20.59
Current Price $3.18
Current
$3.18
Target
$17.35
$11.58 $17.35 avg $20.59
Scenario Analysis
Bear Case
$11.58
264.2%
Low target
Base Case
$17.35
+445.6%
Avg target
Bull Case
$20.59
+547.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$11.46
-72.2% from high
52-Week Low
$1.07
+197.2% from low
Target vs 52W High
$17.35
+51.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%